Honigman Advises Helius Medical Technologies on $9.1 Million Public Offering: Law Firm, Attorneys, Lawyers

At a combined public offering price of $3.27 per share and accompanying warrants, Helius Medical Technologies, Inc. (NASDAQ: HSDT), a neurotech company dedicated to providing a novel therapeutic neuromodulation approach for balance and gait deficits, closed its public offering of 2,768,600 shares of Class A common stock (or common stock equivalents) and warrants to purchase up to 2,768,600 shares of common stock. June 6, 2025, was the closing date of the offering.